2026

Plasma PlGF as a Potential Biomarker in Ramucirumab-Based Second-Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase II Part of the RAMIRIS Trial
Hille J, Lorenzen S, Pauligk C, Gensch V, Thuss-Patience P, Goekkurt E, Ettrich T, Lordick F, Bokemeyer C, Müller C, Reichardt P, Sökler M, Pink D, Probst S, Goetze T, Al-Batran S, Loges S, Janning M
INT J CANCER. 2026;159(7):1817-1828.

2025

Acute Lymphoblastic Leukemia Characterized by Rare BCR:FGFR1 Translocation: A Case Report With Literature Review.
Al-Bazaz M, Forstreuter A, Hammada I, Hille J, Wagner J, Reinert J, Wehrhahn J, Bokemeyer C, Fiedler W
CASE REP HEMATOL. 2025;2025(1):.

2024

Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells
Rieckmann L, Spohn M, Ruff L, Agorku D, Becker L, Borchers A, Krause J, O'Reilly R, Hille J, Velthaus-Rusik J, Beumer N, Günther A, Willnow L, Imbusch C, Iglauer P, Simon R, Franzenburg S, Winter H, Thomas M, Bokemeyer C, Gagliani N, Krebs C, Sprick M, Hardt O, Riethdorf S, Trumpp A, Stoecklein N, Peine S, Rosenstiel P, Pantel K, Loges S, Janning M
MOL CANCER. 2024;23(1):93.

2023

Case Report of a DDX41 Germline Mutation in a Family with Multiple Relatives Suffering from Leukemia
Wagner J, Al-Bazaz M, Forstreuter A, Hammada M, Hille J, Papingi D, Bokemeyer C, Fiedler W
BIOMEDICINES. 2023;12(1):.

Letzte Aktualisierung aus dem FIS: 12.09.2026 - 01:31 Uhr